These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27246230)

  • 21. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC; Shi ZY; Chen YH; Wang FD
    J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
    Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
    J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses.
    Tamang MD; Moon DC; Kim SR; Kang HY; Lee K; Nam HM; Jang GC; Lee HS; Jung SC; Lim SK
    Vet Microbiol; 2017 Mar; 201():252-256. PubMed ID: 28284617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of linezolid resistance in hepatobiliary infections caused by Enterococcus faecium.
    Niebel M; Perera MT; Shah T; Marudanayagam R; Martin K; Oppenheim BA; David MD
    Liver Transpl; 2016 Feb; 22(2):201-8. PubMed ID: 26335577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.
    Bender JK; Fleige C; Klare I; Fiedler S; Mischnik A; Mutters NT; Dingle KE; Werner G
    PLoS One; 2016; 11(11):e0167042. PubMed ID: 27893790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
    Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial coagulase-negative staphylococci in Belgrade: between Scylla and Charybdis.
    Protic D; Savic D; Andjelkovic D; Djukanovic N; Zdravkovic M; Djurasevic SF; Todorovic Z
    J Infect Dev Ctries; 2016 Sep; 10(9):907-912. PubMed ID: 27694722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
    Wang Y; Lv Y; Cai J; Schwarz S; Cui L; Hu Z; Zhang R; Li J; Zhao Q; He T; Wang D; Wang Z; Shen Y; Li Y; Feßler AT; Wu C; Yu H; Deng X; Xia X; Shen J
    J Antimicrob Chemother; 2015 Aug; 70(8):2182-90. PubMed ID: 25977397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology of the infection by resistant Gram-positive microorganisms].
    Cercenado E
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():6-9. PubMed ID: 27608305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid-resistant Enterococcus faecalis: first report in Spain.
    Sánchez-Gómez JC; Fraile-Malmierca F; Valverdé-Romero ED; Sánchez M; García-Rodríguez JA; García-Sánchez JE
    J Chemother; 2006 Aug; 18(4):440-2. PubMed ID: 17024804
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
    Pogue JM; Paterson DL; Pasculle AW; Potoski BA
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1382-8. PubMed ID: 17994519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
    Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
    Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of hospital-acquired linezolid-nonsusceptible enterococci infection in Chongqing, China, 2011-2014.
    Jia X; Ma W; Xu X; Yang S; Zhang L
    Am J Infect Control; 2015 Dec; 43(12):e101-6. PubMed ID: 26315061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of mutation-based linezolid-resistant invasive Enterococcus faecalis in a haemodialysis patient in Norway.
    Thilesen CM; Bjørang O; Skrede T; Aronsen T; Aasnaes B; Sundsfjord A; Hegstad K
    APMIS; 2014 Jan; 122(1):83-4. PubMed ID: 23656533
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns.
    Wang QY; Li RH; Shang XH
    J Chemother; 2015 Feb; 27(2):117-9. PubMed ID: 24835052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
    Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014.
    O'Driscoll C; Murphy V; Doyle O; Wrenn C; Flynn A; O'Flaherty N; Fenelon LE; Schaffer K; FitzGerald SF
    J Hosp Infect; 2015 Dec; 91(4):367-70. PubMed ID: 26520594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients].
    Medell M; Hart M; Batista ML
    Biomedica; 2014 Apr; 34 Suppl 1():50-7. PubMed ID: 24968036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.